NCT05676918 Maternal Well-being in the Postnatal Stage
| NCT ID | NCT05676918 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Complutense de Madrid |
| Condition | Postpartum Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 98 participants |
| Start Date | 2023-01-16 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 98 participants in total. It began in 2023-01-16 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to design and validate an online intervention aimed at promoting well-being in women with postpartum depression. For this, the design of a multicomponent protocol consisting of empirically validated positive interventions and comparing these with a group Cognitive Behavioral Therapy (CBT) is proposed, following the National Institute for Health and Care Excellence (NICE) recommendations for the treatment of depression. Participants will be screened for inclusion in the program if they meet clinical criteria. After that, they will be randomly assigned to a CBT group or a positive psychology intervention (PPI) group.
Eligibility Criteria
Inclusion Criteria: * Women who have been mothers in the last year Exclusion Criteria: * Women who have been mothers in the last month, * Women who meet the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for substance abuse and/or dependence within 30 days prior to study participation, * Women who have a serious mental disorder that makes it difficult to follow the protocol (e.g. serious neurocognitive problems or brain damage; schizophrenia and other psychotic disorders).
Contact & Investigator
Covadonga Chaves, PhD
PRINCIPAL INVESTIGATOR
Universidad Complutense de Madrid
Frequently Asked Questions
Who can join the NCT05676918 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Postpartum Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05676918 currently recruiting?
Yes, NCT05676918 is actively recruiting participants. Contact the research team at cchavesv@psi.ucm.es for enrollment information.
Where is the NCT05676918 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT05676918 clinical trial?
NCT05676918 is sponsored by Universidad Complutense de Madrid. The principal investigator is Covadonga Chaves, PhD at Universidad Complutense de Madrid. The trial plans to enroll 98 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.